BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15146935)

  • 1. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
    Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
    Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
    Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
    Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
    Yamamoto O; Okada Y; Okabe S
    Dig Dis Sci; 1984 May; 29(5):394-401. PubMed ID: 6714055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
    Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
    Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
    Sohn SK; Chang MS; Chung YK; Kim KB; Wook TW; Kim SG; Choi WS
    Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
    Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
    Tariq M; Parmar NS; Ageel AM
    J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel xanthine derivative on experimental ulcers in rats.
    Tanaka T; Morioka Y; Gebert U
    Arzneimittelforschung; 1993 May; 43(5):558-62. PubMed ID: 8329000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
    Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.